Bill > S05433

This bill amends the New York Public Health Law to expand the role of licensed pharmacists in infectious disease testing. Specifically, pharmacists will now be authorized to order and administer Food and Drug Administration (FDA)-approved infectious disease tests, including tests to detect the disease itself or its antibodies, subject to federal Clinical Laboratory Improvement Act (CLIA) certificate of waiver requirements. Pharmacists must complete appropriate training developed by the state department of health before conducting these tests. The bill also designates pharmacists as qualified healthcare professionals who can direct limited service laboratories to perform such tests, but only for FDA-approved and CLIA-waived tests. The tests can be conducted on patients who are either suspected of having an infectious disease or suspected of having recovered from an infectious disease. This legislation represents an expansion of pharmacists' clinical capabilities, potentially improving access to diagnostic testing in community pharmacy settings.

Health and Social Services

https://www.nysenate.gov/legislation/bills/2025/S5433